Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Viruses

ABSTRACT: Coronavirus genes were unexpectedly detected in the unidentified clinical samples stored using next-generation sequencing

PROVIDER: PRJDB13880 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR397174.fastq.gz	Fastqsanger.gz
	DRR397175.fastq.gz	Fastqsanger.gz
	DRR397176.fastq.gz	Fastqsanger.gz
	DRR397177.fastq.gz	Fastqsanger.gz
	DRR397177_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 43

Similar Datasets

Viruses

Project description:Clinical / animal samples Raw sequence reads

| PRJNA291127 | ENA

Project description:Metagenomic Next-Generation Sequencing (mNGS) of Clinical Samples

| PRJNA588503 | ENA

Project description:Clinical Metagenomic Next-Generation Sequencing

| PRJNA844122 | ENA

Fusion genes in EGFR mutant lung cancer

Project description:The clinical significance of gene fusions detected by DNA-based next generation sequencing remains unclear as resistance mechanisms to EGFR tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC). Through comprehensive evaluation of potential drug resistance-imparting fusion oncogenes in EGFR mutant lung cancers, we selected candidate samples to be further validated by confirmatory assay. Here, we performed RNA sequencing as an unbiased genome-wide method to identify novel oncogenic fusions. In 11 samples from 10 patients, 3 different fusion callers consistently detected only the DLG1-BRAF fusion in sample 6. None of other putative fusions detected by DNA-based hybrid capture sequencing were validated.We concluded that only a subset of putative fusion was validated by RNA-seq.

2022-08-08 | GSE182323 | GEO

Project description:Genotypic characteristics of hepatoblastoma as detected by next generation sequencing and their correlation with clinical efficacy

| PRJNA751247 | ENA

Proteomic analysis of SARS-CoV-2: A clinical landscape of COVID-19 proteome and host responses

Project description:A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 and continues to be a global health challenge. To understand viral disease biology, we have carried out proteo-genomic analysis using next generation sequencing (NGS) and mass-spectrometry on nasopharyngeal swabs of COVID-19 patients to examine clinical genome and proteome. Our proteomic analysis, for the first time identified 13 different SARS-CoV-2 proteins from the clinical swabs. Additionally, host proteome analysis revealed several key host proteins to be uniquely expressed in COVID-19 patients. Besides revealing aspects of host-virus pathogenesis, our study opens avenues to develop better diagnostic markers and therapeutic strategies.

2021-06-28 | PXD021896 | Pride

Mwalili2020 - SEIR model of COVID-19 transmission and environmental pathogen prevalence

Project description:Objective: Coronavirus disease 2019 (COVID-19) is a pandemic respiratory illness spreading from person-to-person caused by a novel coronavirus and poses a serious public health risk. The goal of this study was to apply a modified susceptible-exposed-infectious-recovered (SEIR) compartmental mathematical model for prediction of COVID-19 epidemic dynamics incorporating pathogen in the environment and interventions. The next generation matrix approach was used to determine the basic reproduction number R0. The model equations are solved numerically using fourth and ffth order Runge–Kutta methods. Results: We found an R0 of 2.03, implying that the pandemic will persist in the human population in the absence of strong control measures. Results after simulating various scenarios indicate that disregarding social distancing and hygiene measures can have devastating effects on the human population. The model shows that quarantine of contacts and isolation of cases can help halt the spread on novel coronavirus.

2024-09-02 | BIOMD0000000964 | BioModels

LC-MS/MS Analysis of Respiratory Viruses

Project description:Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and other respiratory viruses -Coronavirus OC43, Coronavirus 229E, Influenza A/H1N1, Influenza A/H3N2, Influenza B, Respiratory Syncytial Virus RSV A and RSV B - were analysed by bottom-up proteomics of viral cultures. High coverage of viral proteins was acheived after culturing in serum-free conditions when compared to cultures grown using standard conditions including 2% fetal bovine serum.

2022-10-13 | PXD028562 | Pride

Survey of RNA viruses present in East African maize with symptoms of maize lethal necrosis.

Project description:Next-generation sequencing survey of maize plants exhibiting symptoms of maize lethal necrosis, collected from Kenyan and Ethiopian farmers in August 2014. Up to three samples per site were sequenced, and sites were separated by at least 10km. Data contains maize transcriptome and a variety of RNA viruses.

2018-12-01 | E-MTAB-7002 | biostudies-arrayexpress

microRNA profiling in the aqueous humor of highly myopic eyes by next generation sequencing

Project description:Purpose: To characterize microRNAs (miRNAs) and their possible roles in high myopia by using next generation sequencing Methods: Aqueous humor samples were obtained from 15 highly myopic eyes and 15 cataract eyes at the onset of surgery. miRNA next generation sequencing and bioinformatics analyses were performed using RNA extracted from aqueous humor samples. Results: A total of 341 miRNAs were detected in the aqueous humor samples of highly myopic eyes; 201 miRNAs were detected in the aqueous humor samples of cataractous control eyes. A total of 249 mature miRNAs and 17 novel miRNAs were differentially expressed during myopia. Possible pathways regulated by these aberrantly expressed miRNAs included the TNF, MAPK, PI3K-Akt, and HIF-1 signaling pathways. Conclusions: The current study provided an overall view of miRNA profiling in the aqueous humor of highly myopic eyes. These profiles may be associated with myopia pathogenesis, and are potential biomarkers.

2021-12-15 | GSE142359 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data